Dr Geoffrey Ku

Geoffrey Ku, MD is a Medical Oncologist who specializes in the treatment of malignancies of the gastrointestinal tract at Memorial Sloan Kettering Cancer Center in New York, New York. He is an Associate Attending physician and Head of the Esophagogastric Section on the Gastrointestinal Oncology Service and a Member of the Cellular Therapy Service, both in the Department of Medicine. His research focuses on the evaluation of novel therapies, including cellular therapies, and combined modality treatments for esophagogastric cancer. He is a member of the Esophagogastric Task Force of the National Cancer Institute and of the Gastrointestinal (non-Colorectal Cancer) committee of the NRG Cooperative Group.

He graduated from the University of Pennsylvania School of Medicine and completed his Internal Medicine Residency in New York Presbyterian Hospital, Weill Cornell Campus, prior to his Medical Oncology Fellowship at MSKCC. Post-fellowship, he spent one year at the Immune Monitoring Facility at MSKCC, which is part of the Ludwig Center for Cancer Immunotherapy.